Back to News
Market Impact: 0.25

Forget Chip Stocks: The Best Way to Profit From AI Is This 31%-Yielding ETF

NVDATSMAVGOASMLAMDONNFLXNDAQ
Technology & InnovationArtificial IntelligenceInvestor Sentiment & PositioningCompany FundamentalsAnalyst InsightsMarket Technicals & Flows
Forget Chip Stocks: The Best Way to Profit From AI Is This 31%-Yielding ETF

The VanEck Semiconductor ETF (SMH) is a 26-stock, chip-focused ETF with roughly 20% weight in Nvidia and just under 11% in Taiwan Semiconductor; it charges a 0.35% expense ratio (about $35 per $10,000) versus a 0.44% average for active funds. Over the past 10 years the fund averaged nearly 31% annual returns versus ~19% for the Nasdaq-100 (QQQ), though it declined 34% in 2022 and posted a 49% gain in 2025, reflecting higher volatility than broad-market indexes. The piece highlights the ETF as a cost-competitive way to gain diversified semiconductor exposure while warning investors to expect concentrated-sector risk and to maintain a multi-year investment horizon.

Analysis

Market structure: The AI-driven demand shock concentrates upside into a handful of high-end logic and design names (NVDA, TSM, AVGO, ASML, AMD) while commoditized analog and legacy suppliers (ON) lag; SMH’s top-20 concentration (NVDA ~20%, TSM ~11%) increases idiosyncratic tail risk but preserves aggregate outperformance if AI capex continues. Pricing power sits with advanced fabs (TSM) and EUV suppliers (ASML), signalling tight supply for leading-edge nodes into 2026–2028 and upward pricing pressure for wafer starts and specialty gases by +10–20% under continued demand growth. Risk assessment: Key tail risks include US export restrictions or a Taiwan disruption (low-probability, high-impact) that could shave 30–60% off revenues for exposed vendors within 6–18 months, and a demand shock if AI hyperscalers pause capex (a 20–30% revenue downside in a severe pullback). Hidden dependencies: NVDA’s roadmap is capacity-constrained by TSMC node availability and ASML delivery slots; catalysts to watch (next 30–90 days) are NVDA/TSM/AVGO earnings and ASML shipment cadence. Trade implications: Core exposure via a 2–3% SMH position captures diversified upside; tactical concentrated longs (NVDA 1–2%, TSM 1.5%) with defined buy-the-dip levels (add on 8–12% pullback) are appropriate over 6–18 months. Use options: buy NVDA 3–6 month 5–10% OTM call spreads if IV rank <60% (cap premium), sell 1–3 month 5–10% OTM covered calls on SMH when IV > historical 12-month mean to harvest yield, and consider long-protective SMH puts if SMH drops >15% from current levels. Contrarian angles: Consensus understates concentration risk — a concentrated NVDA-driven rally can reverse quickly; historical chip cycles (2017–19) show >30% mean reversion after peaks, so valuation discipline matters. Mispricings: ASML and TSM may be under-owned relative to their structural supply-side leverage; unintended consequence of ETF flows is liquidity transfer to smaller names within SMH, potentially creating idiosyncratic drawdowns of 20–40% in mid-cap holdings despite ETF outperformance.